Mode
Text Size
Log in / Sign up
N/A N=612 Randomized Double-blind Health Services Research

Interrupting HIV and TB Stigma in the Household in Uganda

Hiv · Tuberculosis · Social Behavior · Stigma, Social · Stigmatization

Enrolled (actual)
612
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcome: Primary: Proportion of Contacts Accepting HIV Testing — 279; 172 Participants — p=0.004

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Social Support (Behavioral)
Age
Pediatric, Adult, Older Adult · 15+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Jul 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Contacts Accepting HIV Testing
279; 172 0.004 sig
SECONDARY
Change in Score of Perceived HIV Stigma
2.57; -0.21 0.358
SECONDARY
Change in Score of Perceived TB Stigma
0.47; -2.52 0.199
SECONDARY
Change in Effects of Perceived HIV Stigma on HIV Test Uptake
2.59; -0.17 0.03 sig
SECONDARY
Change in Effects of Perceived TB Stigma on HIV Test Uptake
-0.46; -2.34 0.64
SECONDARY
Proportion of Index Patient Nominated Household Members Who Accept HIV Test
58; 33 0.452
SECONDARY
Number of Social Support Household Contacts Deciding to Test for HIV
196 0.264

Summary

The investigators will carry out a prospective, household cluster-randomized, implementation trial evaluating a complex, multi-component, social and behavioral intervention designed to normalize the acceptance of HIV testing in the household and increase diagnosis of HIV.

Eligibility Criteria

Index Patient and Household Eligibility:

  • Index patient is eligible for contact investigation (TB patient of any age identified in the facility's National TB and Leprosy Programme (NTLP) TB Treatment Register as initiating treatment or returning for 2-week follow-up)
  • Index patient or legal guardian agrees to study procedures in addition to routine contact investigation
  • Index patient has at least 2 self-reported household contacts age 15 or above
  • Household is within the boundaries of the Kampala Capital City Authority, Uganda
  • Does not have multi-drug resistant (MDR) TB

Contact Participant Eligibility:

  • Household contact age ≥15 years
  • Agrees to study procedures in addition to routine contact investigation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05124665). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search